Gamaleya: Russian COVID-19 Treatment Drug May Get Approval By End of 2022

MOSCOW (Sputnik) - The Russian Gamaleya research center has developed the chemical compounds to create a drug to treat COVID-19 and expects to get it approved by the end of next year after clinical trials, Denis Logunov, the center's deputy head, said on Sunday.